ArticleVeterinary world2025
The protective effects of Saudi propolis against hepatic injury induced by gold nanoparticles in adult male albino rats.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Exploring Therapeutic Potential ofCurrent topics in medicinal chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Gold nanoparticles (GNPs) are widely used in industrial and medical applications due to their unique properties but may induce oxidative stress and hepatotoxicity. Propolis, a bee-derived natural product with potent antioxidant and anti-inflammatory properties, shows promise as a hepatoprotective agent. This study evaluates the protective effects of Saudi propolis against GNP-induced hepatic damage by examining oxidative stress, lipid metabolism, and liver function. This study aimed to investigate the hepatoprotective effects of Saudi propolis against oxidative damage and lipid dysregulation induced by GNPs in male albino rats. Materials and Methods: A total of 180 adult male rats were divided into six groups: (1) Control (saline), (2) Propolis (100 mg/kg), (3) GNPs (10 nm, 0.2 mg/kg/day), (4) GNPs (30 nm, 0.2 mg/kg/day), (5) GNPs (10 nm) + propolis, and (6) GNPs (30 nm) + propolis. Treatments were administered daily for 5, 10, or 15 days. Blood and liver samples were analyzed for oxidative stress markers, liver enzymes (aspartate transaminase, alanine transaminase, alkaline phosphatase, and glutamyl transpeptidase), lipid peroxidation (malondialdehyde [MDA]), antioxidant enzymes (superoxide dismutase [SOD] and glutathione peroxides [GPx]), and lipid profiles (cholesterol [CHO] and triglyceride [TG]). Results: Rats treated with GNPs showed elevated liver enzymes, lipid peroxidation, and oxidative stress, accompanied by increased CHO and TG levels. In contrast, co-administration of Saudi propolis significantly mitigated these effects, restoring MDA, SOD, and GPx levels close to control values. The hepatoprotective effects were more pronounced for 10 nm GNPs than 30 nm. After 15 days, TG levels returned to near-normal levels, while CHO levels improved but remained elevated. Conclusion: Saudi propolis exhibits significant protective effects against GNP-induced hepatic damage, primarily due to its antioxidant properties and ability to reduce oxidative stress and lipid peroxidation. The findings provide evidence for the therapeutic potential of propolis in managing nanoparticle-induced liver toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.